Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZUW NASDAQ:ATAKW NYSE:BVS NASDAQ:DRTSW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.06$0.05$0.00▼$0.15N/AN/A32,101 shs1 shsATAKWAurora Technology Acquisition$0.02-17.5%$0.01$0.01▼$0.04N/AN/A85,679 shs7,833 shsBVSBioventus$6.26-3.5%$6.69$6.02▼$14.38$514.22M0.84430,112 shs391,050 shsDRTSWAlpha Tau Medical$0.25-9.1%$0.24$0.09▼$0.50N/AN/A20,966 shs1,057 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%0.00%+85.43%+62.25%+4.26%ATAKWAurora Technology Acquisition0.00%-18.78%+14.29%+66.67%+58.42%BVSBioventus-2.26%-12.18%+2.20%-17.01%-9.36%DRTSWAlpha Tau Medical-8.39%-3.09%+6.36%+14.09%+0.40%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ABVSBioventus2.7717 of 5 stars3.40.00.00.01.13.31.3DRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUWAnzu Special Acquisition Corp I 0.00N/AN/AN/AATAKWAurora Technology Acquisition 0.00N/AN/AN/ABVSBioventus 2.75Moderate Buy$13.75119.65% UpsideDRTSWAlpha Tau Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BVS, DRTSW, ANZUW, and ATAKW Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/7/2025BVSBioventusCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$12.005/7/2025BVSBioventusCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$15.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/ABVSBioventus$567.70M0.91$0.50 per share12.58$2.80 per share2.24DRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUWAnzu Special Acquisition Corp IN/AN/A0.00∞N/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ABVSBioventus-$156.23M-$0.48N/A13.61N/A-7.11%15.61%4.01%N/ADRTSWAlpha Tau MedicalN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/ABVSBioventusN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANZUWAnzu Special Acquisition Corp IN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/ABVSBioventus1.851.410.99DRTSWAlpha Tau MedicalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ABVSBioventus62.94%DRTSWAlpha Tau MedicalN/AInsider OwnershipCompanyInsider OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ABVSBioventus33.00%DRTSWAlpha Tau MedicalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUWAnzu Special Acquisition Corp I2N/AN/ANot OptionableATAKWAurora Technology AcquisitionN/AN/AN/ANot OptionableBVSBioventus1,20082.14 million54.46 millionNot OptionableDRTSWAlpha Tau Medical80N/AN/ANot OptionableBVS, DRTSW, ANZUW, and ATAKW HeadlinesRecent News About These CompaniesDRTSW Alpha Tau Medical Ltd. WT EXPJuly 3, 2025 | seekingalpha.comAlpha Tau Medical Ltd. Approves Key Proposals at Annual MeetingJune 17, 2025 | tipranks.comAlpha Tau Medical Ltd. CFO Raphi Levy to Present at Jefferies Global Healthcare Conference on June 5, 2025May 28, 2025 | quiverquant.comQAlpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate UpdateMay 20, 2025 | finanznachrichten.deAlpha Tau receives FDA approval to start trial for patients with recurrent GBMApril 2, 2025 | markets.businessinsider.comCiti Sticks to Their Buy Rating for Alpha Tau Medical Ltd (DRTS)March 22, 2025 | markets.businessinsider.comAlpha Tau Medical Ltd.: Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate UpdateMarch 13, 2025 | finanznachrichten.deAlpha Tau Medical Ltd (DRTS) Gets a Buy from Piper SandlerMarch 13, 2025 | markets.businessinsider.comAlpha Tau receives MDSAP certificationFebruary 24, 2025 | markets.businessinsider.comAlpha Tau Achieves MDSAP Certification, Boosting Global Expansion EffortsFebruary 24, 2025 | tipranks.comDRTS Stock Soars to 52-Week High, Reaching $4.08 Amid Healthcare SurgeJanuary 17, 2025 | msn.comAlpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir ...December 18, 2024 | messenger-inquirer.comMAlpha Tau Medical Ltd. Appoints Maya Netser to Board of Directors as Meir Jakobsohn Completes TermDecember 17, 2024 | quiverquant.comQAlpha Tau to Showcase Innovations at Oncology SymposiumDecember 6, 2024 | tipranks.comAlpha Tau Medical Ltd. (DRTS)December 3, 2024 | finance.yahoo.comPositive Outlook for Alpha Tau Medical Ltd Amid Clinical and Regulatory MilestonesNovember 22, 2024 | markets.businessinsider.comPiper Sandler Issues a Buy Rating on Alpha Tau Medical Ltd (DRTS)November 21, 2024 | markets.businessinsider.comAlpha Tau Medical Advances in Cancer Treatment TechnologyNovember 20, 2024 | markets.businessinsider.comAlpha Tau Medical Ltd. Progresses with Alpha DaRT® as FDA Approves Key Trials and Financial Update Reveals Strong Cash PositionNovember 19, 2024 | quiverquant.comQAlpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 19, 2024 | markets.businessinsider.comMedia Sentiment Over TimeBVS, DRTSW, ANZUW, and ATAKW Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUW$0.06 0.00 (0.00%) As of 07/11/2025Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Aurora Technology Acquisition NASDAQ:ATAKW$0.02 0.00 (-17.53%) As of 07/11/2025Aurora Technology Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on businesses in the technology companies, including artificial intelligence, blockchain, quantum computing, and electric vehicles in Asia and North America. The company was incorporated in 2021 and is based in San Francisco, California.Bioventus NYSE:BVS$6.26 -0.23 (-3.54%) Closing price 04:00 PM EasternExtended Trading$6.26 +0.00 (+0.08%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.Alpha Tau Medical NASDAQ:DRTSW$0.25 -0.03 (-9.06%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
